US FDA

The U.S. Food and Drug Administration (FDA) has issued a warning letter to Novo Nordisk A/S (NYSE:NVO), marking another regulatory strike on the pharmaceutical giant over the last six months following a pattern of safety and marketing lapses. Systemic Failures In Safety Data In a letter dated March...